Skip to main content
OpenTrials
Completed

NCT Number: NCT04874753

The Effect of COVID-19 Pandemia on Follow up of Patients With Chronic Kidney Disease

COVID-19 pandemic affected the admission of patients to the hospital especially the older patients (> 65 years old) because of curfews and the reluctance of patients to apply to the hospitals. Chronic kidney disease is characterized with the progressive loss of kidney function over the time and regular follow-up of patients for their kidney function and treatment of complications is recommended in these patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Covid19 COVID-19 Chronic Disease Chronic Kidney Diseases Coronaviridae Infections Coronavirus Infections Disease Attributes Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Infections Kidney Diseases Lung Diseases Male Urogenital Diseases Nidovirales Infections Pathologic Processes Pathological Conditions, Signs and Symptoms Pneumonia Pneumonia, Viral Proteinuria RNA Virus Infections Renal Insufficiency Renal Insufficiency, Chronic Respiratory Tract Diseases Respiratory Tract Infections Signs and Symptoms Urination Disorders Urogenital Diseases Urologic Diseases Urological Manifestations Virus Diseases

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Usak University

Uşak, 64100, Turkey (Türkiye)

About this study

The chronis kidney disease patients followed in Nephrology outpatient unit are going to be enrolled in the study and their kidney functions (calculated with the mdrd formula to asses the estimated glomerular filtration rate (eGFR)) will be evaluated 6 months before and after the COVID-19 pandemia. And the rate of initiation of renal replacement therapies and the change in proteinuria will be evaluated 6 months before and after the COVID-19 pandemic.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with chronic kidney disease on regular follow-up for 6 months before the COVID19 pandemic.

Exclusion criteria

  • patients without chronic kidney disease
  • patients not on routine follow-up for 6 months before the COVID19 pandemic

Treatment and study plan

change in kidney function and proteinuria

Other

change in eGFR nad proteinuria in patients with chronic kidney disease

Primary outcomes

  1. eGFR change

    Time frame: 6 months

    a rise or decrease in eGFR

  2. change in proteinuria

    Time frame: 6 months

    increase or decrease in ptoteinuria levels

Secondary outcomes

  1. initiation of renal replacement therapies

    Time frame: 6 months

    need for hemodialysis or peritoneal dialysis

Sponsors and collaborators

Lead sponsor

Uşak University

Other

Registry information

Acronym: COVID19-CKD

Important dates

Study start
2020
Primary completion
2020
Study completion
2021
First posted
May 6, 2021
Registry last updated
May 6, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.